The characteristics and mechanism of simvastatin loaded lipid nanoparticles to increase oral bioavailability in rats
Authors:
- Huihui BuHBHuihui Bu
- Zhiwei GaoZGZhiwei Gao
- Yan HuangYHYan Huang
- Fang GaoFGFang Gao
- Yaping LiYLYaping Li
- 1 July 2010
- journal article
- research article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 394 (1-2) , 147-153
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Lipid nanocarriers improve paclitaxel transport throughout human intestinal epithelial cells by using vesicle-mediated transcytosisJournal of Controlled Release, 2009
- Glyceryl Monooleate/Poloxamer 407 Cubic Nanoparticles as Oral Drug Delivery Systems: I. In Vitro Evaluation and Enhanced Oral Bioavailability of the Poorly Water-Soluble Drug SimvastatinAAPS PharmSciTech, 2009
- Enhancement of gastrointestinal absorption of quercetin by solid lipid nanoparticlesJournal of Controlled Release, 2009
- Nanoemulsion Preparations of the Anticancer Drug Dacarbazine Significantly Increase Its Efficacy in a Xenograft Mouse Melanoma ModelMolecular Pharmaceutics, 2008
- An orally delivered small-molecule formulation with antiangiogenic and anticancer activityNature Biotechnology, 2008
- Approaches for the development of solid and semi-solid lipid-based formulationsAdvanced Drug Delivery Reviews, 2008
- Chromatography–mass spectrometry methods for the quantitation of statins in biological samplesJournal of Pharmaceutical and Biomedical Analysis, 2007
- Na+ and pH dependence of proline and β‐alanine absorption in rat small intestineActa Physiologica, 2006
- Improved oral bioavailability of cyclosporin A in male Wistar ratsInternational Journal of Pharmaceutics, 2002
- Relative Lipophilicities, Solubilities, and Structure–Pharmacological Considerations of 3-Hydroxy-3-Methylglutaryl-Coenzyme A (HMG-CoA) Reductase Inhibitors Pravastatin, Lovastatin, Mevastatin, and SimvastatinJournal of Pharmaceutical Sciences, 1991